Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Agence de La Biomédecine | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
Differentiated thyroid cancer is the third cause of cancer in young men of childbearing age. Its treatment by irradiation with Radioactive Iodine 131 therapy (RAT) could alter spermatogenesis and result in azoospermia and permanent infertility. A preventive gametes cryopreservation was recommended before RAT, but without mentioning a period of teratogenic risk transmissible to the offspring. To date, RAT impact on human sperm nucleus is poorly known or even unknown, notably on telomere length.
Our objective is to define RAT effects on human sperm nucleus by in vitro irradiation exposure of human spermatozoa to mimicking that of the gonads in the context of irradiation with iodine131 used for thyroid cancer. We will analyze standard sperm parameters, major DNA alterations and telomere length using molecular and cellular assays. Nucleus morphology and chromatin organization will also be analyzed using 3D bio-imaging. This study will permit to optimize the indications for the preservation of fertility.
Our main objective is to measure the in vitro impact of irradiation treatment on sperm nuclear quality such as DNA fragmentation and oxidation, chromatin condensation and organisation, nucleus morphology and notably sperm telomere length (STL).
The secondary objectives are :
Our final goal is to provide a significant improvement of men fertility diagnosis and optimize our fertility preservation practices.
To this end, we will expose ejaculated human spermatozoa (n = 90) at different (low and moderate) doses of gamma or X photons to mimic gonads irradiation. Absorbed doses by the samples were calculated using the GATE Monte Carlo platform (version 8.2). Experiment geometry settings were modelled as three dimension voxelized volumes inside the software by assigning a shape, size, distance and density for all the volumes created. All measurements will be made on surplus samples from men undergoing routine semen analysis at the Center for Reproductive Medicine, after receiving their written informed consent. Semen samples are collected and subdivided into 3 arms to analyse sperm quality after:
Before (fresh state) and after each treatment we will analyse:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| control arm "fresh" | Fresh semen treated without irradiation before cryopreservation |
| |
| control arm "cryopreserved" | cryopreserved semen without irradiation (n=60) |
| |
| acute irradiation at low dose | Pelvis scanning : acute irradiation (1 or 2 second) using low dose (n=30), |
| |
| long irradiation at low dose | Bone scintigraphy : long irradiation (3h) using low dose (n=30), |
| |
| long irradiation at medium dose | Radioactive Iodine 131 therapy (RAT) applied for thyroid cancer : long irradiation (3h) using medium dose (n=60), |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Cryopreserved semen | Other | sperm will be frozen in Cryosperm® cryoprotectant medium (Origio). The samples will be packaged in previously identified high security straws (Cryobiosystem). Slow freezing of the straws will be carried out using the Nanodigicool® programmable device (Cryobiosystem). |
| Measure | Description | Time Frame |
|---|---|---|
| To measure in vitro the impact of an ionizing radiation treatment on sperm nuclear quality and in particular the size of telomeres. | To achieve this goal, we will expose human sperm to an irradiation dose of I131 to mimic the irradiation of gonads and sperm. Reliquat of semen will be cryopreserved (control condition). After thawing, the same sample will be subdivised into 2 groups in order to analyze the sperm quality :
| 01/01/2018-01/01/2022 |
| Measure | Description | Time Frame |
|---|---|---|
| To measure in vitro the impact of an irradiation dose of I131 on sperm nuclear quality, notably on STL. | All measurements are made on surplus samples from men undergoing routine semen analysis at the Center for Reproductive Medicine, after receiving their written informed consent. Semen samples will be collected and subdivided into 3 arms to analyse sperm quality after:
Before (fresh state) and after each treatment we will analyse:
|
Not provided
Inclusion Criteria:
Exclusion Criteria:
-
Not provided
Not provided
All measurements are made on surplus samples from men undergoing routine semen analysis at the Center for Reproductive Medicine, after receiving their written informed consent
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Lise Laclautre, PharmD | Contact | 04 73 75 49 63 | 34 | promo_interne_drci@chu-clermontferrand.fr |
| Name | Affiliation | Role |
|---|---|---|
| Hanae PONS-REJRAJI, PhD | University Hospital, Clermont-Ferrand | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU de Clermont-Ferrand | Recruiting | Clermont-Ferrand | 63000 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D013964 | Thyroid Neoplasms |
| ID | Term |
|---|---|
| D004701 | Endocrine Gland Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D006258 | Head and Neck Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Acute and low irradiation | Other | sperm sample will be placed on the scanner's processing table to be exposed for 1 to 2 seconds. Several dose levels will then be made in order to limit the value of 17 mGy |
|
| Long and low irradiation | Other | sperm sample will be exposed to gamma radiation by adding a solution of Tc99m for 3 hours. |
|
| Long and medium irradiation | Other | sperm sample will be exposed to gamma radiation by adding a solution of I131 for 3 hours |
|
| 01/01/2018-01/01/2022 |
| to measure RAT impact on sperm parameters (vitality, motility and morphology) | All measurements are made on surplus samples from men undergoing routine semen analysis at the Center for Reproductive Medicine, after receiving their written informed consent. Semen samples will be collected and subdivided into 3 arms to analyse sperm quality after:
| 01/01/2018-01/01/2022 |
| To measure in vitro the impact of cryopreservation on sperm nuclear quality, notably on STL, chromatin organisation and nucleus morphology | All measurements are made on surplus samples from men undergoing routine semen analysis at the Center for Reproductive Medicine, after receiving their written informed consent. Semen samples will be collected and subdivided into 3 arms to analyse sperm quality after:
Before (fresh state) and after each treatment we will analyse:
| 01/01/2018-01/01/2022 |
| to evaluate RAT impact on human sperm cells in comparison with cryopreservation | We will compare effects induced by RAT and cryopreservation on each sperm sample. In order to limit the bias, for each irradiation treatment, a sample of sperm cells (cryopreserved control) will be treated under identical conditions. | 01/01/2018-01/01/2022 |
| to evaluate the impact of different doses and types of irradiation on human sperm cells | All measurements are made on surplus samples from men undergoing routine semen analysis at the Center for Reproductive Medicine, after receiving their written informed consent. Semen samples will be collected and subdivided into 3 arms to analyse sperm quality after:
Irradiation exposure will be realised under 3 conditions:
| 01/01/2018-01/01/2022 |
| to establish relations between potential alterations of standards sperm parameters (vitality, motility and morphology) and nuclear sperm parameters (DNA fragmentation and oxidation, chromatin condensation and organisation, nucleus morphology and STL. | We will correlate the effects induced by on vitality, motility and morphology and nuclear sperm parameters (DNA fragmentation and oxidation, chromatin condensation and organisation, nucleus morphology and STL. | 01/01/2018-01/01/2022 |
| D004700 |
| Endocrine System Diseases |
| D013959 | Thyroid Diseases |